Serial analysis of circulating T gamma/delta lymphocyte subpopulations in Graves' disease. 1998

S Sasián, and J Rojano, and I Gavilán, and M Aguilar, and L Escobar, and J A Girón
Service of Internal Medicin, Hospital Universitario Puerta del Mar, Facultad de Medicina, Cádiz, Spain.

In the present paper the distribution of peripheral blood T gamma/delta lymphocytes in Graves' disease patients is analyzed in order to correlate them with disease activity and with prognosis. Eighteen patients with Graves' disease, 24 patients with Hashimoto's thyroiditis and 32 sex- and age-matched healthy control subjects were studied. Peripheral blood CD3+ alpha/beta and gamma/delta T lymphocytes as well as CD4+ and CD8+ T cells, and CD19 (B) lymphocytes were analyzed by cytofluorometry. At diagnosis, patients who required a radical treatment for thyrotoxicosis control showed a significant decrease of T gamma/delta lymphocytes and an increase of B cells when compared with those who maintained the euthyroid state after methimazole. No correlation was detected between the percentages of these subpopulations and serum free thyroxine. This decreased proportion did not normalize after methimazole or radical treatments. These results suggest that the cytotoxic T gamma/delta compartment of the immune system is altered in patients with Graves' disease.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011989 Receptors, Thyrotropin Cell surface proteins that bind pituitary THYROTROPIN (also named thyroid stimulating hormone or TSH) and trigger intracellular changes of the target cells. TSH receptors are present in the nervous system and on target cells in the thyroid gland. Autoantibodies to TSH receptors are implicated in thyroid diseases such as GRAVES DISEASE and Hashimoto disease (THYROIDITIS, AUTOIMMUNE). Receptors, Thyroid Stimulating Hormone,TSH Receptors,Thyroid Stimulating Hormone Receptors,Thyrotropin Receptors,LATS Receptors,Receptor, LATS Immunoglobulins,Receptors, LATS,Receptors, Long-Acting Thyroid Stimulator,Receptors, TSH,TSH Receptor,Thyroid Stimulating Hormone Receptor,Thyrotropin Receptor,Receptor, TSH,Receptor, Thyrotropin,Receptors, Long Acting Thyroid Stimulator
D005260 Female Females
D006111 Graves Disease A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy). Basedow's Disease,Exophthalmic Goiter,Goiter, Exophthalmic,Graves' Disease,Basedow Disease,Hyperthyroidism, Autoimmune,Basedows Disease,Disease, Basedow,Disease, Basedow's,Disease, Graves,Disease, Graves',Exophthalmic Goiters,Goiters, Exophthalmic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody

Related Publications

S Sasián, and J Rojano, and I Gavilán, and M Aguilar, and L Escobar, and J A Girón
February 1983, Journal of clinical & laboratory immunology,
S Sasián, and J Rojano, and I Gavilán, and M Aguilar, and L Escobar, and J A Girón
December 1987, Clinical endocrinology,
S Sasián, and J Rojano, and I Gavilán, and M Aguilar, and L Escobar, and J A Girón
February 1983, Acta endocrinologica,
S Sasián, and J Rojano, and I Gavilán, and M Aguilar, and L Escobar, and J A Girón
November 1980, Clinical immunology and immunopathology,
S Sasián, and J Rojano, and I Gavilán, and M Aguilar, and L Escobar, and J A Girón
September 2003, Pediatric research,
S Sasián, and J Rojano, and I Gavilán, and M Aguilar, and L Escobar, and J A Girón
January 1986, Medicina cutanea ibero-latino-americana,
S Sasián, and J Rojano, and I Gavilán, and M Aguilar, and L Escobar, and J A Girón
January 1985, Medicina cutanea ibero-latino-americana,
S Sasián, and J Rojano, and I Gavilán, and M Aguilar, and L Escobar, and J A Girón
December 1983, Gastroenterology,
S Sasián, and J Rojano, and I Gavilán, and M Aguilar, and L Escobar, and J A Girón
May 1985, Archives of ophthalmology (Chicago, Ill. : 1960),
S Sasián, and J Rojano, and I Gavilán, and M Aguilar, and L Escobar, and J A Girón
November 1989, Immunology today,
Copied contents to your clipboard!